Compare LAB & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAB | NRC |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 365.2M | 390.8M |
| IPO Year | 2008 | 1997 |
| Metric | LAB | NRC |
|---|---|---|
| Price | $0.93 | $17.61 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 70.6K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | 61.54 | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | $101,937,000.00 | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | ★ N/A | $0.35 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $0.87 | $11.01 |
| 52 Week High | $1.72 | $22.79 |
| Indicator | LAB | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 61.12 |
| Support Level | $0.90 | $17.85 |
| Resistance Level | $1.02 | $18.28 |
| Average True Range (ATR) | 0.06 | 0.92 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 34.52 | 90.98 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.